These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2665088)

  • 1. Perspective on antiplatelet drugs.
    O'Brien JR
    Semin Thromb Hemost; 1989 Apr; 15(2):171-2. PubMed ID: 2665088
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiplatelet agents and their therapeutic use].
    Lecompte T
    Rev Prat; 1999 Oct; 49(15):1627-33. PubMed ID: 10581992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives in the antiplatelet therapy of thrombotic disorders.
    Breddin HK
    Semin Thromb Hemost; 1989 Apr; 15(2):144-9. PubMed ID: 2665085
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development.
    Patrono C; Patrignani P; Rocca B; Landolfi R
    Thromb Haemost; 1995 Jul; 74(1):396-400. PubMed ID: 8578493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clopidogrel. Actions, pharmacokinetics, clinical studies].
    Wunderlich H; Beer J; Allgaier C
    Med Monatsschr Pharm; 2002 Dec; 25(12):425-9. PubMed ID: 12522913
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
    Zettl H; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.
    Vila PM; Zafar MU; Badimon JJ
    Platelets; 2009 Dec; 20(8):531-8. PubMed ID: 19845440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy with aspirin: from clinical trials to practice.
    Goodnight SH
    Thromb Haemost; 1995 Jul; 74(1):401-5. PubMed ID: 8578495
    [No Abstract]   [Full Text] [Related]  

  • 9. [The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides].
    Marrakchi N; Guermazi S; El Ayeb M
    Arch Inst Pasteur Tunis; 1997; 74(1-2):9-15. PubMed ID: 15945171
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet drugs.
    De Meyer SF; Vanhoorelbeke K; Broos K; Salles II; Deckmyn H
    Br J Haematol; 2008 Aug; 142(4):515-28. PubMed ID: 18513285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
    Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
    Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atherothrombosis and thrombocyte function inhibitors].
    Internist (Berl); 1997 Aug; 38(8 Suppl Atheroth):1-8. PubMed ID: 9330654
    [No Abstract]   [Full Text] [Related]  

  • 13. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
    Jennings LK
    Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet antiaggregants in cardiopathies].
    Gómez-Jaume A; Izaguirre R
    Arch Inst Cardiol Mex; 1992; 62(6):557-63. PubMed ID: 1285666
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemostatic tests for the diagnosis of thrombosis. Examination of thrombotic disease by impedance aggregometry using whole blood].
    Mizuno A; Isobe J; Shima K
    Rinsho Byori; 1988 Jun; 36(6):632-9. PubMed ID: 3210313
    [No Abstract]   [Full Text] [Related]  

  • 16. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.
    Kuliczkowski W; Witkowski A; Polonski L; Watala C; Filipiak K; Budaj A; Golanski J; Sitkiewicz D; Pregowski J; Gorski J; Zembala M; Opolski G; Huber K; Arnesen H; Kristensen SD; De Caterina R
    Eur Heart J; 2009 Feb; 30(4):426-35. PubMed ID: 19174428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
    van Giezen JJ; Humphries RG
    Semin Thromb Hemost; 2005 Apr; 31(2):195-204. PubMed ID: 15852223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptors as targets for antiplatelet therapy.
    Hamilton JR
    Blood Rev; 2009 Mar; 23(2):61-5. PubMed ID: 18644663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [-New aspects in antithrombotic therapy--platelet inhibitors-].
    Terres W; Meinertz T
    Herz; 1996 Feb; 21(1):1-11. PubMed ID: 8647575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents.
    Zhao L; Gaudry L; Dunkley S; Brighton T; Guo ZX; Ye ZL; Luo RZ; Chesterman CN
    Platelets; 2008 Feb; 19(1):24-31. PubMed ID: 18231935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.